[Hereditary Alzheimer's disease with amyloid angiopathy caused by amyloid precursor protein locus]

H Axer1, S Hüge, C Wilhelm

  • 1Klinik für Psychiatrie und Psychotherapie, Friedrich-Schiller-Universität, Jena, Deutschland. Hubertus.Axer@med.uni-jena.de

Der Nervenarzt
|September 11, 2008
PubMed

Insights

Early-onset dementia was linked to amyloid precursor protein (APP) locus duplication. This genetic cause explains both Alzheimer's-like cerebrospinal fluid changes and cerebral amyloid angiopathy findings.

Area of Science:

  • Neuroscience
  • Genetics
  • Neurology

Background:

  • Early-onset dementia presents diagnostic challenges.
  • Autosomal dominant inheritance suggests a strong genetic component.
  • Distinguishing between Alzheimer's disease and other dementias is crucial.

Observation:

  • A patient presented with early-onset autosomal dominant dementia.
  • Cerebrospinal fluid (CSF) analysis revealed elevated tau and reduced amyloid beta (42:40 ratio), indicative of Alzheimer's disease.
  • Cerebral MRI showed vascular lesions, white-matter changes, and microhemorrhages, suggesting cerebral amyloid angiopathy.

Findings:

  • Gene analysis identified amyloid precursor protein (APP) locus duplication as the cause of hereditary Alzheimer's dementia.
  • The patient exhibited a combination of CSF biomarkers for Alzheimer's disease and MRI findings consistent with cerebral amyloid angiopathy.
  • This constellation of findings is characteristic of APP locus duplication.

Implications:

  • APP locus duplication should be considered in cases of early-onset dementia with a family history and specific neuroimaging/CSF findings.
  • Enhanced genetic analysis, including APP gene analysis, is recommended for such patients.
  • Understanding the genetic basis of dementia aids in diagnosis and potential therapeutic strategies.

Related Concept Videos

Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...